News Blog

Today Alina has her first day in the lab. She will investigate RIPK2 driven effects in small cell lung cancer (SCLC). Welcome Alina!

Today Ilayda has her first day in the lab. She is working on the IZKF funded project on small cell lung cancer (SCLC) and will decipher novel molecular mechanisms regulating the anti-tumor immune response. Welcome Ilayda!

Today Daniel has his first day in the lab. He will support the IZKF funded project on small cell lung cancer and investigate novel molecular mechanisms regulating the anti-tumor immune response. Welcome Daniel!

Today Mary-Lyn has her first day in the lab. She will support our group by cell culture work and qPCR experiments. Moreover, she will generate preliminary data regarding the regulation of circardian clock genes in squamous cell cell lung cancer. Welcome Mary-Lyn!

We are looking for a highly motivated team members to join our young and open-minded research group. If you are enthusiastic about supporting the translation of preclinical findings into personalized medicine, we look forward to receiving your detailed application.

We are happy to get the opportunity to present our work at the Clinican Scientist Programm Retreat. Lydia will give a talk about therapeutic targeting of small-cell lung cancer metastasis.

Today Anna has her first day in the lab. She will investigate novel molecular mechanisms in lung cancer metastasis related to alterations in glycosylation pathways in tumor cells. Welcome Anna!

It was pleasure to meet Prof. Choi and Prof. Shin at the Samsung Medical Center in Seoul during the Program of the NRF-DFG Symposium. We look forward to fruitful collaborations.

Lydia participated at the Expert Selection Committee of the La Caixa Research Health 2023 Call in the section Oncology.

We are exited to join the annual Symposium of the TRR305 "Striking a moving target: From mechanisms of metastatic organ colonisation to novel systemic therapies".